The Newest Battles Between EGFR Monoclonal Antibodies and Resistant Tumor Cells
Epidermal development issue receptor (EGFR) is a tyrosine kinase receptor concerned in homeostatic regulation of regular cells and carcinogenesis of epithelial malignancies. With speedy improvement of the precision drugs period, a collection of recent therapies concentrating on EGFR are underway.
- 4 EGFR monoclonal antibody medication (cetuximab, panitumumab, nimotuzumab, and necitumumab) are already on the market, and a dozen different EGFR monoclonal antibodies are in medical trials.
- Right here, we comprehensively evaluation the newly recognized organic properties and anti-tumor mechanisms of EGFR monoclonal antibodies.
- We summarize not too long ago accomplished and ongoing medical trials of the basic and new EGFR monoclonal antibodies.
- Extra importantly, in response to our new commonplace, we re-classify the advanced evolving tumor cell resistance mechanisms, together with these involving exosomes, non-coding RNA and the tumor microenvironment, in opposition to EGFR monoclonal antibodies.
- Lastly, we analyzed the constraints of EGFR monoclonal antibody remedy, and mentioned the present methods overcoming EGFR associated drug resistance.
- This evaluation will assist us higher perceive the most recent battles between EGFR monoclonal antibodies and resistant tumor cells, and the long run instructions to develop anti-tumor EGFR monoclonal antibodies with sturdy results.
A high-throughput neutralizing antibody assay for COVID-19 prognosis and vaccine analysis
Virus neutralization stays the gold commonplace for figuring out antibody efficacy. Subsequently, a high-throughput assay to measure SARS-CoV-2 neutralizing antibodies is urgently wanted for COVID-19 serodiagnosis, convalescent plasma remedy, and vaccine improvement.
Right here, we report on a fluorescence-based SARS-CoV-2 neutralization assay that detects SARS-CoV-2 neutralizing antibodies in COVID-19 affected person specimens and yields comparable outcomes to plaque discount neutralizing assay, the gold commonplace of serological testing.
The fluorescence-based neutralization assay is restricted to measure COVID-19 neutralizing antibodies with out cross reacting with affected person specimens with different viral, bacterial, or parasitic infections. Collectively, our method gives a speedy platform that may be scaled to display folks for antibody safety from COVID-19, a key parameter needed to securely reopen native communities.
LEC antibody |
|||
70R-LG003 | Fitzgerald | 50 ug | EUR 312 |
Description: Affinity purified Goat polyclonal LEC antibody |
LEC/NCC-4 Human Recombinant |
|||
rAP-0241 | Angio Proteomie | Inquiry | Ask for price |
Recombinant Human LEC (CCL16) Protein |
|||
PROTO15467-1 | BosterBio | 20ug | EUR 380.4 |
Description: LEC is a CC chemokine that can signal through the CCR8 and CCR1 receptors. It is expressed in the liver, spleen, and thymus. LEC is chemotactic towards monocytes and lymphocytes but not neutrophils. Recombinant human LEC is an 11.2 kDa protein containing 97 amino acid residues, including the four conserved cysteine residues present in CC chemokines. |
Biotinylated Anti-Human LEC Goat Polyclonal Antibody |
|||
TA328364 | Origene Technologies GmbH | 50 µg | Ask for price |
Human LEC Recombinant Protein Lyophilized |
|||
IHULECRLY5UG | Innovative research | each | EUR 341 |
Description: Human LEC Recombinant Protein Lyophilized |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
7-01792 | CHI Scientific | 5µg | Ask for price |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
7-01793 | CHI Scientific | 20µg | Ask for price |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
7-01794 | CHI Scientific | 1mg | Ask for price |
Recombinant Human LEC/NCC-4 (CCL16) |
|||
HECCP-1601 | Cyagen | 5ug | Ask for price |
LEC protein |
|||
30R-AL013 | Fitzgerald | 20 ug | EUR 312 |
Description: Purified recombinant Human LEC protein |
LEC Chemokine(LEC66) Antibody |
|||
BNC040066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF405S conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC040066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF405S conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC040067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF405S conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC040067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF405S conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC810066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF680R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC810066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF680R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC810067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF680R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC810067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF680R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC940066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF594 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC940066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF594 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC940067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF594 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC940067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF594 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC880066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF488A conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC880066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF488A conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC880067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF488A conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC880067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF488A conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC430066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF543 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC430066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF543 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC430067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF543 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC430067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF543 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC050066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF405M conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC050066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF405M conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC050067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF405M conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC050067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF405M conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC470066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF647 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC470066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF647 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC470067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF647 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC470067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF647 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC400066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF640R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC400066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF640R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC400067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF640R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC400067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF640R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC550066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF555 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC550066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF555 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC550067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF555 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC550067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF555 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC610066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF660R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC610066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF660R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC610067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF660R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC610067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF660R conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC800066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF680 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC800066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF680 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC800067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF680 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC800067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF680 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC700066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF770 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC700066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF770 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC700067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF770 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC700067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF770 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC680066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF568 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNC680066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), CF568 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC680067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF568 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNC680067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), CF568 conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCP0066-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against LEC Chemokine(LEC66), PerCP conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNCP0067-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against LEC Chemokine(LEC67), PerCP conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCR0066-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against LEC Chemokine(LEC66), RPE conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNCR0067-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against LEC Chemokine(LEC67), RPE conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNUB0066-100 | Biotium | 100uL | EUR 250.8 |
Description: Primary antibody against LEC Chemokine(LEC66), Concentration: 0.2mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNUB0066-500 | Biotium | 500uL | EUR 549.6 |
Description: Primary antibody against LEC Chemokine(LEC66), Concentration: 0.2mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNUB0067-100 | Biotium | 100uL | EUR 250.8 |
Description: Primary antibody against LEC Chemokine(LEC67), Concentration: 0.2mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNUB0067-500 | Biotium | 500uL | EUR 549.6 |
Description: Primary antibody against LEC Chemokine(LEC67), Concentration: 0.2mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCA0066-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against LEC Chemokine(LEC66), APC conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNCA0067-250 | Biotium | 250uL | EUR 459.6 |
Description: Primary antibody against LEC Chemokine(LEC67), APC conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCAP0066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCAP0066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNCAP0067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNCAP0067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCB0066-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC66), Biotin conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNCB0066-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC66), Biotin conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNCB0067-100 | Biotium | 100uL | EUR 238.8 |
Description: Primary antibody against LEC Chemokine(LEC67), Biotin conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC67) Antibody |
|||
BNCB0067-500 | Biotium | 500uL | EUR 652.8 |
Description: Primary antibody against LEC Chemokine(LEC67), Biotin conjugate, Concentration: 0.1mg/mL |
LEC Chemokine(LEC66) Antibody |
|||
BNUM0066-50 | Biotium | 50uL | EUR 474 |
Description: Primary antibody against LEC Chemokine(LEC66), 1mg/mL |
Drug Tolerant Anti-drug Antibody Assay for Infliximab Remedy in Medical Follow Identifies Constructive Instances Earlier
A subgroup of sufferers handled with infliximab lose response to the remedy and one purpose for that is the event of anti-drug antibodies (ADA). If used optimally, measuring drug and ADA degree might result in a extra customized and environment friendly remedy regime, and allow identification of ADA-positive sufferers earlier than the underlying illness flares or allergic reactions happen.
With the usage of a drug-tolerant ADA assay which might detect ADA no matter drug ranges within the pattern, we decided the affect of ADA on remedy failure to infliximab. The goals of this examine had been to estimate the real-life optimum serum infliximab (sIFX) degree and set a medical threshold worth for a drug-tolerant ADA assay. Trough ranges of sIFX had been measured with ELISA. Free ADA was measured with two drug-sensitive strategies (ELISA and a bioassay) and one drug-tolerant methodology (PandA).
Two real-life cohorts handled with infliximab had been included; a cross-sectional cohort together with sufferers with inflammatory rheumatic ailments (n = 270) and a potential cohort of rheumatoid arthritis (RA) sufferers (n = 73) adopted for 1 yr.
Regular vary of sIFX was estimated from the possible cohort and an arbitrary optimum drug degree was set to be between 1 and 6 μg/mL. Utilizing this vary, optimum sIFX was present in solely 60% (163/270) of the sufferers within the cross-sectional cohort. These sufferers had considerably higher remedy response than these with a drug degree below 1 μg/mL, who had an ADA frequency of 34% (19/56) utilizing the drug-tolerant methodology.
Within the potential cohort, the drug-tolerant assay might establish 34% (53/155 samples) as ADA optimistic in samples with sIFX degree >0.2 μg/mL. ADA had been seldom detected in sufferers with >1 μg/mL sIFX, with three fascinating exceptions. A clinically related ADA threshold was decided to be >three RECL as measured with the drug-tolerant assay. In a real-life setting, there was a considerable variety of sufferers with suboptimal drug ranges and a proportion of those had ADA.
Each too low and too excessive drug ranges correlated with worse illness, however for various causes. Including a drug-tolerant assay enabled detection of ADA earlier and no matter drug degree at time of sampling.
Rabbit Anti-Human alpha-Tubulin IgG |
|||
TUBA13-A | Alpha Diagnostics | 100 ul | EUR 578.4 |
Rabbit Anti-human Topoisomerase II alpha (TOP2 alpha) IgG, aff pure |
|||
TOP2A11-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Recombinant (E.Coli) Human p38 alpha/SAPK2 alpha |
|||
RP-675 | Alpha Diagnostics | 1 ug | EUR 343.2 |
Tumor necrosis factor alpha TNF-? (72 - 82), human (AA: Pro-Leu-Ala-Gln-Ala-Val-Arg-Ser-Ser-Ser-Arg) (MW: 1171.33) |
|||
SP-86635-5 | Alpha Diagnostics | 5 mg | EUR 343.2 |
Monoclonal Anti-Human alpha-Tubulin IgG |
|||
TUBA12-M | Alpha Diagnostics | 100 ul | EUR 578.4 |
Alpha 2-Antiplasmin, Human Plasma |
|||
A2AP15-100 | Alpha Diagnostics | 100 ug | EUR 196.8 |
Alpha 1-Antitrypsin, Human Plasma |
|||
A1AT15-N | Alpha Diagnostics | 1 mg | EUR 196.8 |
Chicken Anti-Human alpha 1 anti-trypsin IgG/Y |
|||
A1AT12-A | Alpha Diagnostics | 100 ul | EUR 578.4 |
Goat Anti-Human Tumor Necrosis Factor-Alpha (TNF-alpha) IgG #2, aff. Pure (neutralzing) |
|||
TNFA13-A | Alpha Diagnostics | 100 ul | EUR 578.4 |
Guinea pig Tumor Necrosis Factor Alpha (TNF-a) ELISA Kit, 96 tests, Quantitative |
|||
9870 | Alpha Diagnostics | 1 Kit | EUR 927.6 |
Rabbit Anti-Human p73 alpha antiserum # 2 |
|||
P73A12-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Rabbit Anti-Human Glutathione Transferase alpha (GST-alpha) antiserum |
|||
GSTA12-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Alpha 1-Antichymotrypsin , Human Plasma |
|||
A1CT15-N-100 | Alpha Diagnostics | 100 ug | EUR 196.8 |
Rabbit Anti-Human Estrogen receptor alpha (ER-alpha) peptide IgG |
|||
ERA12-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Recombinant (E.Coli) purified human Tumor Necrosis Factor-Alpha (TNF-alpha), biologically active |
|||
TNFA15-R-10 | Alpha Diagnostics | 10 ug | EUR 270 |
Rabbit Anti-Human p73 alpha/beta antiserum # 1 |
|||
P73A11-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Monoclonal anti-human Alpha (FSH-Alpha), IgG clone 3 aff pure |
|||
FSHA12-M | Alpha Diagnostics | 1 mg | EUR 578.4 |
Goat Anti-Human Lutenizing Hormone Alpha (LH-Alpha) IgG aff pure |
|||
LHA13-A | Alpha Diagnostics | 1 mg | EUR 343.2 |
Tumor necrosis factor alpha TNF-? (78-96) (human) (AA: His-Thr-Ile-Ser-Arg-Ile-Ala-Val-Ser-Tyr-Gln-Thr-Lys-Val-Asn-Leu-Leu-Ser-Ala) (MW: 2101.45) |
|||
SP-89730-1 | Alpha Diagnostics | 1 mg | EUR 196.8 |
human Topoisomerase II alpha (TOP2 alpha) Control/blocking peptide |
|||
TOP2A11-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
Goat Anti-human Alpha fetoprotein (AFP) IgG, pure |
|||
AFP13-A | Alpha Diagnostics | 1 mg | EUR 781.2 |
Tumor necrosis factor alpha TNF-? (46-65) (human) (AA: Asn-Gln-Leu-Val-Val-Pro-Ser-Glu-Gly-Leu-Tyr-Leu-Ile-Tyr-Ser-Gln-Val-Leu-Phe-Lys) (MW: 2310.74) |
|||
SP-89728-1 | Alpha Diagnostics | 1 mg | EUR 489.6 |
Goat Anti-human Chorionic Gonadotropin Alpha (hCG-Alpha) IgG aff pure |
|||
HCGA13-A | Alpha Diagnostics | 1 mg | EUR 343.2 |
Rabbit Anti-Human HE2 alpha IgG #1, aff pure |
|||
HE2A11-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Rabbit Anti-Human p73 alpha/ IgG # 2, aff pure |
|||
P73A12-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Tumor necrosis factor alpha TNF-? (31 - 45), human (AA: Arg-Arg-Ala-Asn-Ala-Leu-Leu-Ala-Asn-Gly-Val-Glu-Leu-Arg-Asp) (MW: 1667.90) |
|||
SP-86636-1 | Alpha Diagnostics | 1 mg | EUR 196.8 |
Rabbit Anti-Rat TNF-alpha Converting Enzyme (TACE), IgG aff. Pure |
|||
TACE11-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Anti-Human TNF alpha |
|||
GWB-619378 | GenWay Biotech | 1 mg | Ask for price |
Anti-Human TNF alpha |
|||
GWB-8F48ED | GenWay Biotech | 1 mL | Ask for price |
Anti-Human TNF-&alpha |
|||
GWB-BIG93C | GenWay Biotech | 500ug | Ask for price |
Recombinant purified, human Interleukin-1 alpha (IL-1 alpha), active |
|||
IL1A15-R-10 | Alpha Diagnostics | 10 ug | EUR 416.4 |
Recombinant Human Alpha-Synuclein |
|||
RP-847 | Alpha Diagnostics | 20 ug | EUR 196.8 |
Rabbit Anti-Human alpha-Tubulin IgG-HRP Conjugate |
|||
TUBA13-HRP | Alpha Diagnostics | 100 ul | EUR 518.4 |
Human Alpha-Thrombin (human plasma), purified |
|||
TBNA16-N-100 | Alpha Diagnostics | 100 ug | EUR 196.8 |
Rabbit Anti-Human alpha-Tubulin IgG-Biotin Conjugate |
|||
TUBA13-BTN | Alpha Diagnostics | 100 ul | EUR 562.8 |
Rabbit Anti-Human Resistin-Like protein alpha (RELM-alpha/FIZZ1) antiserum #2 |
|||
RELMA12-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Goat Anti-Human Alpha 1-Antitrypsin (A1AT) IgG, unlabeled |
|||
A1AT11-A | Alpha Diagnostics | 100 ul | EUR 489.6 |
Chicken Anti-Human Alpha 2 Macroglobulin (A2M) IgG/Y |
|||
A2MG13-A | Alpha Diagnostics | 100 ul | EUR 578.4 |
Goat Anti-Ferret IgA (alpha), unlabeled |
|||
70519 | Alpha Diagnostics | 0.5 mg | EUR 255.6 |
Monoclonal Anti-Human Chorionic Gonadotropin Alpha (hCG-alpha) IgG #1, aff pure |
|||
HCGA11-M | Alpha Diagnostics | 1 mg | EUR 343.2 |
Rabbit Anti-Human p73 alpha/beta IgG # 1, aff pure |
|||
P73A11-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Monoclonal Anti-human Chronionic Gonadotropin Alpha (hCG-Alpha) IgG #2, caff pure |
|||
HCGA12-M | Alpha Diagnostics | 1 mg | EUR 343.2 |
Rabbit Anti-Rat Glutathione Transferase alpha (GST-alpha) antiserum |
|||
GSTA11-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Rabbit Anti-Human Alpha Defensin 4 (NP-4) antiserum #1 |
|||
HDEFA41-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Rabbit Anti-Human Alpha Defensin 5 (NP-5),antiserum #1 |
|||
HDEFA51-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Rabbit Anti-Human Alpha Defensin 6 (NP-6) antiserum #1 |
|||
HDEFA61-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Mouse Monoclonal Anti-human Alpha fetoprotein (AFP) (clone 1) |
|||
AFP11-M | Alpha Diagnostics | 1 mg | EUR 578.4 |
Mouse Monoclonal Anti-human Alpha fetoprotein (AFP) (clone 2) |
|||
AFP12-M | Alpha Diagnostics | 1 mg | EUR 578.4 |
Monoclonal anti-human Lutenizing Hormone Alpha (LH-Alpha) IgG, clone 2 aff pure |
|||
LHA12-M | Alpha Diagnostics | 1 mg | EUR 343.2 |
Tumor necrosis factor alpha TNF-? (10-36) (human) (AA: Asp-Lys-Pro-Val-Ala-His-Val-Val-Ala-Asn-Pro-Gln-Ala-Glu-Gly-Gln-Leu-Gln-Trp-Leu-Asn-Arg-Arg-Ala-Asn-Ala-Leu) (MW: 2996.41) |
|||
SP-89727-1 | Alpha Diagnostics | 1 mg | EUR 270 |
Recombinant (E.Coli) Human Thyrostimulin Alpha |
|||
RP-595 | Alpha Diagnostics | 10 ug | EUR 343.2 |
Recombinant purified human TNF Receptor 2 (TNFR2/TNF-RII, Etannercept/TNF-R75, p75TNFR) protein (E.Coli, His-tag) |
|||
TNFR25-R-20 | Alpha Diagnostics | 10 ug | EUR 343.2 |
Rabbit Anti-Human GABAa Receptor alpha 1 (GAA1) Antiserum #1 |
|||
GAA11-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Sheep Anti-Human alpha 1 antichymotrypsin (ACT) IgG, aff pure |
|||
ACT11-A | Alpha Diagnostics | 100 ug | EUR 489.6 |
Goat Anti-Human Alpha 1-Antitrypsin (A1AT) IgG, HRP conjugate |
|||
A1AT11-HRP | Alpha Diagnostics | 100 ul | EUR 489.6 |
Alpha 1-Antitrypsin (A1AT), Human protein control for WB |
|||
A1AT11-C | Alpha Diagnostics | 100 ul | EUR 343.2 |
Alpha 2-HS Glycoprotein, Human Plasma |
|||
A2HG15-N | Alpha Diagnostics | 1 mg | EUR 343.2 |
Goat Anti-Human IgA (alpha chain sp.) IgG-Biotin Conjugate |
|||
10040 | Alpha Diagnostics | 0.5 mg | EUR 242.4 |
Goat Anti-Human Alpha 1-Antitrypsin (A1AT) IgG, Biotin conjugate |
|||
A1AT11-BT | Alpha Diagnostics | 100 ul | EUR 489.6 |
Rabbit Anti-Human GABAa Receptor alpha 1 (166-269aa) IgG #1, aff pure |
|||
GAA14-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Goat Anti-Ferret IgA (alpha)-HRP conjugate |
|||
70520 | Alpha Diagnostics | 0.5 ml | EUR 285.6 |
Alpha 2-Macroglobulin (A2M), Human Plasma |
|||
A2MG15-N | Alpha Diagnostics | 1 mg | EUR 196.8 |
Rabbit Anti-Human Core-binding factor alpha (CBFA1) antiserum #1 |
|||
CBFA11-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Monoclonal Anti-Human alpha 1 antichymotrypsin (ACT) IgG, aff pure |
|||
ACT12-M | Alpha Diagnostics | 100 ug | EUR 578.4 |
Rabbit Anti-C. perfringens alpha toxin antiserum |
|||
CPA11-S | Alpha Diagnostics | 100 ul | EUR 548.4 |
Rabbit Anti-Human Resistin-Like protein alpha (RELM-alpha/FIZZ1) IgG #2, aff. Pure |
|||
RELMA12-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Recombinant (E.Coli) Human Crystallin Alpha A |
|||
RP-611 | Alpha Diagnostics | 20 ug | EUR 196.8 |
Recombinant (E.Coli) Human Crystallin Alpha B |
|||
RP-612 | Alpha Diagnostics | 20 ug | EUR 196.8 |
Human Alpha Feto Protein (AFP) High Pure |
|||
AFP15-N | Alpha Diagnostics | 1 mg | EUR 854.4 |
Goat Anti-human Alpha 2-Macroglobulin (A2M) protein IgG, unlabeled |
|||
A2MG11-A | Alpha Diagnostics | 100 ul | EUR 416.4 |
Rabbit Anti-Human GABAa Receptor alpha 2 (GAA2) IgG, aff. Pure |
|||
GAA21-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
TNF alpha, Human |
|||
E34M046H | EnoGene | 20 μg | EUR 155 |
Recombinant (E.Coli) Human Estrogen Receptor Alpha |
|||
RP-940 | Alpha Diagnostics | 2 ug | EUR 416.4 |
Human Alpha Synuclein (A30P) Recombinant protein |
|||
SYN-A30P-R | Alpha Diagnostics | 50ug | EUR 315.6 |
Human Alpha Synuclein (A53T) Recombinant protein |
|||
SYN-A53T-R | Alpha Diagnostics | 50ug | EUR 315.6 |
Monoclonal Anti-Human/mouse/rat HSP90 alpha/beta IgG, aff pure |
|||
HSP901-M | Alpha Diagnostics | 100 ul | EUR 578.4 |
Monoclonal anti-human Follicle Stimulating Hormone Alpha (FSH-Alpha), IgG clone 2 aff pure |
|||
FSHA11-M | Alpha Diagnostics | 1 mg | EUR 578.4 |
Human HE2 alpha Control/blocking peptide #1 |
|||
HE2A11-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
Human p73 alpha Control/blocking peptide #2 |
|||
P73A12-P | Alpha Diagnostics | 100 ug | EUR 196.8 |
Rabbit Anti-Human IL-2 receptor alpha, soluble (IL2RsA/CD25) IgG |
|||
CD251-A | Alpha Diagnostics | 100 ul | EUR 578.4 |
Rabbit Anti-Human Alpha Defensin 4 (NP-4), IgG #1, aff pure |
|||
HDEFA41-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Rabbit Anti-Human Alpha Defensin 5 (NP-5),, IgG #1, aff pure |
|||
HDEFA51-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Rabbit Anti-Human Alpha Defensin 6 (NP-6) IgG #1, aff pure |
|||
HDEFA61-A | Alpha Diagnostics | 100 ug | EUR 578.4 |
Sheep Anti-Human Serum Fetuin (Alpha-2 HS-Glycoprotein, AHSG, A2HS) IgG |
|||
FETA15-A | Alpha Diagnostics | 100 ul | EUR 489.6 |
Recombinant (E.Coli) Human Casein Kinase 2 alpha |
|||
RP-666 | Alpha Diagnostics | 3 ug | EUR 708 |
Recombinant (Sf9) Human Protein Kinase C alpha |
|||
RP-676 | Alpha Diagnostics | 10 ug | EUR 343.2 |
Goat Anti-Follicle Stimulating Hormone Alpha (FSH-Alpha) IgG aff pure |
|||
FSH13-A | Alpha Diagnostics | 1 mg | EUR 578.4 |
Monoclonal Anti-Human Fetuin A (Alpha-2 HS-Glycoprotein, AHSG, A2HS) IgG |
|||
FETA13-M | Alpha Diagnostics | 100 ug | EUR 578.4 |
Goat Anti-Rabbit IgA (alpha chain)-HRP conjugate |
|||
20029 | Alpha Diagnostics | 0.5 ml | EUR 315.6 |
Rabbit Anti-Goat IgA (alpha chain)-HRP conjugate |
|||
30120 | Alpha Diagnostics | 0.5 ml | EUR 255.6 |
Chicken Anti-Human Alpha 1 acid glycoprotein (A1AG) IgG/Y, unlabeled |
|||
A1AG12-A | Alpha Diagnostics | 100 ul | EUR 578.4 |